Bullish
Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - Aura Biosciences ( NASDAQ:AURA )
BOSTON, Sept. 03, 2025 ( GLOBE NEWSWIRE ) -- Aura Biosciences, Inc. AURA, a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will present at the H.C.